News & Events

ASU licenses several biotech technologies to Roche

Tue, 11 Oct 2011 20:37:14 -0600

Phoenix Business Journal -- Arizona State University will license several technologies to Basel, Switzerland-based Roche, the world’s largest biotech company. The technologies to develop a new DNA sequencing system were developed by Dr. Stuart Lindsay at the Biodesign Institute at ASU and Dr. Colin Nuckolls, of the Columbia University Nanoscience Center... “ASU is absolutely a remarkable school for tech transfer,” [Lindsay] said. Read more

Roche Licenses Nanopore Sequencing Technologies from Arizona State University and Columbia University for Rapid, Affordable DNA Sequencing

Tue, 11 Oct 2011 20:37:14 -0600

Roche and Arizona Technology Enterprises (AzTE) announced today an agreement to license several technologies developed by Dr. Stuart Lindsay at the Biodesign Institute at Arizona State University and Dr. Colin Nuckolls of the Columbia University Nanoscience Center for the development of a revolutionary DNA sequencing system. The licensed technologies include specialized approaches for DNA base sensing and reading and build on an ongoing collaboration between Roche's sequencing center of excellence, 454 Life Sciences, and IBM to develop and commercialize a single-molecule, nanopore DNA sequencer with the capacity to rapidly decode an individual's complete genome for well below $1000. Read more

A New Prescription for Technology Transfer

Tue, 11 Oct 2011 20:37:14 -0600

We have created 10 prescriptions for technology transfer that may not cure the patient, but would certainly revive it and put it on the solid path to recovery. These steps were determined after consultation with technology transfer and entrepreneurial experts at all levels of Arizona State University. As we move through implementation, we can see some positive results. For example, ASU’s metrics on licensing and startup activities place it in the top ten of institutions with more than $200 million in research expenditures on a cost-adjusted basis. Prescription 1: Hire skilled people who understand both the university and industrial environments. More>

ASU startup ships first memory product

Tue, 11 Oct 2011 20:37:14 -0600

Adesto Technologies Corp., a startup company developing conductive bridging RAM nonvolatile memory technology, has announced that it will ship products this year manufactured by foundry partner Altis Semiconductor SA. In September 2010 the company said it planned to sample a 1-Mbit serial EEPROM replacement as soon as the first quarter of 2011. More >

Inventing the future

Tue, 11 Oct 2011 20:37:14 -0600

Fluoride toothpaste. Rocket fuel. The cancer drug Taxol. LCD displays. Seat belts. Gatorade. Penicillin. The one thing that connects them all is that they were developed through research at universities. Academic researchers are continually developing technologies, products and processes that improve our lives and stimulate the economy. More >

AzTE recognizes inventive ASU faculty

Tue, 11 Oct 2011 20:37:14 -0600

Arizona State University recently honored some of its most inventive and entrepreneurial faculty at a ceremony hosted by Arizona Technology Enterprises (AzTE), the university’s exclusive intellectual property management and technology transfer organization. More >

ASU inks deal with Italian company

Tue, 11 Oct 2011 20:37:14 -0600

Sometimes, however, all the elements come together, as demonstrated by the recently announced licensing agreement between Zcube and Arizona Technology Enterprises (AzTE), ASU's technology venturing arm. The agreement will allow Zcube to use ASU technology to develop and commercialize next-generation medical devices aimed at better monitoring and treatment of chronic respiratory diseases like asthma. Read the full article in IP Marketing Advisor

Cultivating Innovation

Tue, 11 Oct 2011 20:37:14 -0600

Universities seeking ways to commercialize their research work are creating new businesses, jobs and revenue streams

"In most universities there will always be pockets of resistance from folks who have been in academia a long time," [ASU's Augie Cheng] says. "But at ASU I would say that a majority of the faculty do believe that commercial impact is important. They want to see real results from the research." More >

Italian company partners with ASU to perfect asthma treatment

Tue, 11 Oct 2011 20:37:14 -0600

A partnership between Arizona State University and an Italian pharmaceutical firm may help asthma sufferers across the U.S. and Europe breathe easier. Zcube, the research venture of Italian pharmaceutical Zambon Co., and Arizona Technology Enterprises, ASU's technology-venturing arm, have entered into a licensing agreement that will allow Zcube to use ASU technology to develop and commercialize next-generation medical devices to better monitor and treat chronic respiratory diseases like asthma. More >

AzTE highly ranked in recent annual tech transfer survey

Tue, 11 Oct 2011 20:37:14 -0600

According to the report, AzTE scores highly in terms of both inputs (inventions disclosed to AzTE by ASU researchers) and outputs (licensing deals and option agreements). Among U.S. institutions with at least $200 million in research expenditures, AzTE ranked seventh in invention disclosures per $10 million in research. In addition, AzTE ranked sixth for expenditure-adjusted licenses and options. Among the 15 peer institutions designated by the Arizona Board of Regents, ASU through AzTE's activities ranked first and second in those categories, respectively. More >

Medical Device Startup EndoStim Licenses ASU technology

Tue, 11 Oct 2011 20:37:14 -0600

Arizona Technology Enterprises (AzTE) has finalized a series of licensing transactions with EndoStim, Inc., a St. Louis medical device startup, spinning out applications for the groundbreaking neurostimulation technologies developed by an ASU researcher. “The patented technology licensed from AzTE will significantly advance our commercial development of highly miniaturized neurostimulators that can be delivered with a minimally invasive procedure in an outpatient setting,” said Bevil Hogg, EndoStim's President and CEO. More >

AzTE licenses microstimulator technology developed by ASU Professor Bruce Towe

Tue, 11 Oct 2011 20:37:14 -0600

A local doctor and an Arizona State University engineer are working to give acid-reflux sufferers a jolt of relief. The entrepreneurs are helping to develop a tiny device that would stimulate a muscle that blocks stomach acid from bubbling up the digestive tract ... Arizona State University engineering professor Bruce Towe helped create the technology, which includes a microchip that is so tiny that it can fit through a syringe ... "The primary thrust has been to make these devices smaller and smaller," Towe said. "They become less and less invasive and can be introduced into people without surgery." More >

ASU professors honored with Excellence in Research Award

Tue, 11 Oct 2011 20:37:14 -0600

Arizona State University professors Qiang Hu and Milton Sommerfeld were honored with the Excellence in Research Award at the 2010 Arizona Bioindustry Association's BioFest. Hu and Sommerfeld received the award for their on-going research into ways of converting algae to fuel. The two scientists have been working on algae as a renewable source of fuel for more than 25 years. More >

ASU launches Venture Catalyst to help faculty and students launch startups

Tue, 11 Oct 2011 20:37:14 -0600

ASU received a $1 million grant to establish Venture Catalyst at ASU, a new entrepreneurial assistance initiative to help faculty, students and companies launch new startups or accelerate existing ventures. More >

National Academies' report says modern tech transfer system works, could be improved

Tue, 11 Oct 2011 20:37:14 -0600

A National Research Council report evaluating university tech transfer efforts since the 1980 Bayh-Dole Act finds the current system is "unquestionably more effective than its predecessor system … in making research advances available to the public." However, the commission recommended universities focus on disseminating technologies for the public good, rather than raising large sums from licensing. More >